Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2024-2030
... expected to reach USD 75.70 billion in 2024, at a CAGR 11.22% to reach USD 143.43 billion by 2030. Precision medicine refers to the strategy of tailoring disease prevention and treatment solutions by considering the ... Read More
-
2024 Global Forecast for Companion Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to increase from ... Read More
-
2024 Global Forecast for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (Cdx) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Companion Diagnostics: Technologies and Markets
... analysis of the drivers, opportunities, restraints, and challenges in the market. The report details the companion diagnostics market share based on product and service, type of test, technology, and application. The market’s products and services ... Read More
-
Companion Diagnostics Market Size, Trends, Analysis, and Outlook By Products and Services (Assays, Kits & Reagents, Software & Services), By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, Immunohistochemistry, Others), By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032
... Disorders, Cardiovascular Diseases, Infectious Diseases, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032 The global Companion Diagnostics market size is poised to register 10.9% ... Read More
-
Fluorescent In Situ Hybridization Market Size, Trends, Analysis, and Outlook By Probe (Locus Specific Probes, Alphoid/Centromere Repeat Probes, Whole Chromosome Probes), By Application (Cancer Research, Genetic Diseases, Others), By End-User (Research Organizations, Clinical Organizations, Biotechnology Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032
... Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032 The global Fluorescent In Situ Hybridization market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Companion Animal Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Others), By Animal (Dog, Cat, Horse, Others), By End-User (Diagnostics Laboratories, Veterinary Clinics, Hospitals, Research Institute, Others), by Country, Segment, and Companies, 2024-2032
... (Diagnostics Laboratories, Veterinary Clinics, Hospitals, Research Institute, Others), by Country, Segment, and Companies, 2024-2032 The global Companion Animal Diagnostics market size is poised to register 7.7% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Companion Diagnostic Tests in Oncology Market (Detection Technique: Protein Detection, DNA Detection, and Others; and Biomarker: EGFR, KRAS, HER2, BRAF V600E, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Diagnostic Tests in Oncology Market – Scope of Report TMR’s report on the global companion diagnostic tests in oncology market studies the past as well as the current growth trends and opportunities to gain valuable ... Read More
-
Companion Diagnostics Market By Product (Assays, Kits, Reagents, System, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious, Neurology), Sample Type (Tissue, Blood) & Region - Global Forecast to 2029
... 2029 The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6% during the forecast period. Factors such as the increasing ... Read More
-
2024 Global Companion Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
Companion Diagnostics Market Assessment, By Product [Assay, Kits and Reagents, Software and Services], By Technology [Immunohistochemistry, Molecular Diagnostics, In-situ Hybridization, FISH, CISH, Real-time PCR, Gene Sequencing], By Application [Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Gastric Cancer, Others], By End-user [Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Gastric Cancer, Others], By End-user [Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global companion diagnostics market is projected to witness a CAGR of 10.23% during the forecast period ... Read More
-
Companion Diagnostics Market - A Global and Regional Analysis: Focus on Application, End User, Technology, and Region - Analysis and Forecast, 2023-2033
... at $3,762.0 million in 2023 and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033. The growth of the companion diagnostics market is driven by the ... Read More
-
2024 Global: Companion Diagnostics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
FISH Probe Market Size, Trends, Analysis, and Outlook By Technology (Q FISH, FLOW FISH, Others), By Type (DNA, RNA), By Application (Cancer research, Genetic diseases, Others), By End-User (Research, Clinical, Companion diagnostics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global FISH Probe market size is poised to register 8.28% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Cancer Diagnostic Devices Market Size, Trends, Analysis, and Outlook By Product (Molecular Diagnostics, Companion Diagnostics), By Diagnostic (Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Diagnostic Devices market size is poised to register 9.79% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Diagnostic ... Read More
-
Clinical Oncology Next Generation Sequencing Market Size, Trends, Analysis, and Outlook By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges), By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Application (Screening, Companion Diagnostics, Others), By End-User (Hospitals, Clinics, Laboratories), by Region, Country, Segment, and Companies, 2024-2030
... (Screening, Companion Diagnostics, Others), By End-User (Hospitals, Clinics, Laboratories), by Region, Country, Segment, and Companies, 2024-2030 The global Clinical Oncology Next Generation Sequencing market size is poised to register 15.5% growth from 2024 to 2030, ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
-
The 2025-2030 World Outlook for Oncology Companion Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Companion Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tissue Diagnostic Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Companion Diagnostics Assay Kits and Reagents
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Companion Animal Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Growth (Status and Outlook) 2024-2030
... was valued at US$ 9383.3 million in 2023. With growing demand in downstream market, the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) is forecast to a readjusted size of US$ 25340 million by 2030 ... Read More
-
Europe Companion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... USD 2.01 billion by 2029, growing at a CAGR of 9.23% during the forecast period (2024-2029). The COVID-19 pandemic initially had a substantial impact on the companion diagnostics market. The usage of companion diagnostic products ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic ... Read More
Research Assistance
